Mary Tagliaferri is Director of ENZO BIOCHEM INC. Currently has a direct ownership of 312,383 shares of ENZ, which is worth approximately $231,163. The most recent transaction as insider was on Jan 31, 2024, when has been sold 79,365 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 312K
0% 3M change
100.35% 12M change
Total Value Held $231,163

MARY TAGLIAFERRI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2024
BUY
Grant, award, or other acquisition
-
79,365 Added 20.26%
312,383 Common Stock
Feb 09 2023
BUY
Grant, award, or other acquisition
-
75,188 Added 32.53%
155,917 Common Stock, $0.01 pa...
Jul 12 2022
BUY
Grant, award, or other acquisition
-
41,666 Added 34.04%
80,729 Common Stock, $0.01 pa...
Apr 27 2022
BUY
Grant, award, or other acquisition
-
39,063 Added 50.0%
39,063 Common Stock, $0.01 pa...

Also insider at

RYZB
RayzeBio, Inc.
YMAB
Y-mAbs Therapeutics, Inc. Healthcare
MT

Mary Tagliaferri

Director
New York, NY

Track Institutional and Insider Activities on ENZ

Follow ENZO BIOCHEM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENZ shares.

Notify only if

Insider Trading

Get notified when an Enzo Biochem Inc insider buys or sells ENZ shares.

Notify only if

News

Receive news related to ENZO BIOCHEM INC

Track Activities on ENZ